1Hayes AJ,Li LY,Lippman ME.Antivascular therapy:a new approach to cancer treatment[J].BJM,1999,318(4):853-855.
2Kasper HU,Ebert M,Malfertheiner P,et al.Expression of thrombospondin-1 in pancreatic carcinoma:correlation with microvessel density[J].Virchows Arch,2001,438(2):116-120.
3Rice AJ,Steward MA,Quinn GM.Thrombospondin-1 protein expression relates to good prognostic indices in dural carcinoma in situ of the breast[J].J Clin Pathol,2002,55(12):921-925.
4Miyanaga K,Kato Y,Nakamura T,et al.Expression and role of thrombospondins-1 in colorectal cancer[J].Anticancer Res,2002,22(6C):3941-3948.
5Dawson DW,Pearce SF,Zhong R,et al.CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells[J].J Cell Biol,1997,138(3):707-717.
6Yang RC, Han ZC. Angiogenesis in hematologic malignancies and its clinical implications. Int J Hematol, 2002,75:246-256.
7Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1. Matrix Biol, 2000,19:597-561.
8He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A, 1998,95:2509-2514.
9Becker TC, Noel RJ, Coats WS, et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol, 1994,43:161-189.
10Dickson DJ, Shami PJ. Angiogenesis in acute and chronic leukemias. Leukemia Lymphoma, 2001,42:847-853.
